Chronic infusion of salusin-α and -β exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice

被引：83

作者：

Nagashima, Masaharu ^{[1
]}

Watanabe, Takuya ^{[2
]}

Shiraishi, Yuji ^{[1
]}

Morita, Ryou ^{[1
]}

Terasaki, Michishige ^{[1
]}

Arita, Shigeko ^{[2
]}

Hongo, Shigeki ^{[2
]}

Sato, Kengo ^{[3
]}

Shichiri, Masayoshi ^{[4
]}

Miyazaki, Akira ^{[2
]}

Hirano, Tsutomu ^{[1
]}

机构：

[1] Showa Univ, Sch Med, Div Diabet Metab & Endocrinol, Dept Med, Tokyo 1428666, Japan

[2] Showa Univ, Sch Med, Dept Biochem, Tokyo 1428555, Japan

[3] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Unit Clin Anat, Tokyo 1138519, Japan

[4] Kitasato Univ, Sch Med, Dept Diabet Endocrinol & Metab, Sagamihara, Kanagawa 2288555, Japan

来源：

ATHEROSCLEROSIS | 2010年 / 212卷 / 01期

基金：

日本学术振兴会;

关键词：

Salusins; Atherosclerosis; Macrophage; Foam cell formation; Oxidized LDL; FOAM CELL-FORMATION; EXPRESSION; SERUM;

D O I：

10.1016/j.atherosclerosis.2010.04.027

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: Human salusin-alpha and -beta are two-related peptides processed from the same precursor, pre-prosalusin. Our previous in vitro studies have shown that human macrophage foam cell formation is stimulated by salusin-beta but suppressed by salusin-alpha. Thus we investigated the effects of salusin-alpha and -beta on atherosclerotic plaque formation in vivo in apolipoprotein E-deficient (ApoE-/-) mice. Methods: Saline (vehicle), salusin-alpha or -beta (0.6 nmol/kg/h) was continuously infused through osmotic mini-pumps into 13-week-old ApoE-/- mice for 8 weeks. Aortic atherosclerosis, oxidized LDL-induced cholesterol ester accumulation (foam cell formation), and its related gene expression in exudate peritoneal macrophages were determined. Results: After 4-week infusion of salusin-beta, atherosclerotic lesions were 2.6 times greater than vehicle controls, which paralleled 1.9-fold increase in foam cell formation and up-regulation of scavenger receptors (CD36, scavenger receptor class A) and acyl-CoA: cholesterol acyltransferase-1(ACAT1). In contrast, salusin-alpha decreased serum total cholesterol levels by 15% and foam cell formation by 68% associated with ACAT1 down-regulation. After 8-week infusion of salusin-alpha, atherosclerotic lesions were significantly suppressed by 54% compared with vehicle controls. Conclusions: Our study provided the first evidence that salusin-beta accelerates the development of atherosclerotic lesions associated with up-regulation of scavenger receptors and ACAT1 in ApoE(-/-) mice. Whilst, salusin-alpha exerts anti-atherosclerotic effects by suppressing serum total cholesterol levels and ACAT1 expression. (C) 2010 Elsevier Ireland Ltd. All rights reserved.

引用

页码：70 / 77

页数：8

共 15 条

[1] Synthetic salusins as cardiac depressors in rat [J].

Izumiyama, H ;

Tanaka, H ;

Egi, K ;

Sunamori, M ;

Hirata, Y ;

Shichiri, M .

HYPERTENSION, 2005, 45 (03) :419-425

[2] Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages [J].

Miyazaki, A ;

Sakashita, N ;

Lee, O ;

Takahashi, K ;

Horiuchi, S ;

Hakamata, H ;

Morganelli, PM ;

Chang, CCY ;

Chang, TY .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (10) :1568-1574

[3] Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development [J].

Pennings, Marieke ;

Meurs, Illiana ;

Ye, Dan ;

Out, Ruud ;

Hoekstra, Menno ;

Van Berkel, Theo J. C. ;

Van Eck, Miranda .

FEBS LETTERS, 2006, 580 (23) :5588-5596

[4] Presence of immunoreactive salusin-α in human serum and urine [J].

Sato, Kengo ;

Koyama, Takatoshi ;

Tateno, Toru ;

Hirata, Yukio ;

Shichiri, Masayoshi .

PEPTIDES, 2006, 27 (11) :2561-2566

[5] Presence of immunoreactive salusin-β human plasma and urine [J].

Sato, Kengo ;

Sato, Tomohiro ;

Susumu, Teruo ;

Koyama, Takatoshi ;

Shichiri, Masayoshi .

REGULATORY PEPTIDES, 2009, 158 (1-3) :63-67

[6] Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities [J].

Shichiri, M ;

Ishimaru, S ;

Ota, T ;

Nishikawa, T ;

Isogai, T ;

Hirata, Y .

NATURE MEDICINE, 2003, 9 (09) :1166-1172

[7] Reply to 'Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities' [J].

Masayoshi Shichiri .

Nature Medicine, 2007, 13 (6) :661-662

[8] Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice [J].

Shiraishi, Yuji ;

Watanabe, Takuya ;

Suguro, Toshiaki ;

Nagashima, Masaharu ;

Kato, Rina ;

Hongo, Shigeki ;

Itabe, Hiroyuki ;

Miyazaki, Akira ;

Hirano, Tsutomu ;

Adachi, Mitsuru .

JOURNAL OF HYPERTENSION, 2008, 26 (10) :1955-1965

[9] Systemic distribution of salusin expression in the rat [J].

Suzuki, Noriko ;

Shichiri, Masayoshi ;

Akashi, Takumi ;

Sato, Kengo ;

Sakurada, Maya ;

Hirono, Yuki ;

Yoshimoto, Takanobu ;

Koyama, Takatoshi ;

Hirata, Yukio .

HYPERTENSION RESEARCH, 2007, 30 (12) :1255-1262

[10] Human urotensin II accelerates foam cell formation in human monocyte-derived macrophages [J].

Watanabe, T ;

Suguro, T ;

Kanome, T ;

Sakamoto, Y ;

Kodate, S ;

Hagiwara, T ;

Hongo, S ;

Hirano, T ;

Adachi, M ;

Miyazaki, A .

HYPERTENSION, 2005, 46 (04) :738-744

← 1 2 →